All Stories

  1. Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma

    Article • Oncotarget, May 2015, Impact Journals, LLC

    Dr Michele Milella

  2. PTEN: Multiple Functions in Human Malignant Tumors

    Article • Frontiers in Oncology, February 2015, Frontiers

    Dr Michele Milella

  3. Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: A ‘Hard Days Night'

    Article • Current Pharmaceutical Design, June 2014, Bentham Science Publishers

    Dr Michele Milella

  4. Signaling Intermediates (MAPK and PI3K) as Therapeutic Targets in NSCLC

    Article • Current Pharmaceutical Design, June 2014, Bentham Science Publishers

    Dr Michele Milella

  5. Editorial (Thematic Issue: The Lung and Winding Road: Twists and Turns on the Way to Personalized NSCLC Therapy)

    Article • Current Pharmaceutical Design, June 2014, Bentham Science Publishers

    Dr Michele Milella

  6. Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial

    Article • European Journal of Cancer, November 2013, Elsevier

    Dr Michele Milella

  7. Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives

    Article • Expert Review of Anticancer Therapy, June 2013, Taylor & Francis

    Dr Matteo Santoni, Dr Michele Milella, MICHELE DE TURSI, Giovanni Lo Re

  8. Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer:XPD-Lys751Glnpolymorphism strikes back

    Article • International Journal of Cancer, March 2013, Wiley

    Dr Michele Milella

  9. Abstract A2: Autoantibody signature in pancreatic ductal adenocarcinoma.

    Article • Cancer Research, July 2012, American Association for Cancer Research (AACR)

    Dr Michele Milella

  10. Treatment trends in metastatic pancreatic cancer patients: Is it time to change?

    Article • Digestive and Liver Disease, March 2011, Elsevier

    Dr Michele Milella

  11. Biology of Metastatic Renal Cell Carcinoma

    Article • Journal of Cancer, January 2011, Ivyspring International Publisher

    Dr Michele Milella

  12. Third-Line Sorafenib After Sequential Therapy With Sunitinib and mTOR Inhibitors in Metastatic Renal Cell Carcinoma

    Article • European Urology, December 2010, Elsevier

    Dr Michele Milella

  13. Early recurrence risk: aromatase inhibitors versus tamoxifen

    Article • Expert Review of Anticancer Therapy, August 2010, Taylor & Francis

    Dr Michele Milella

  14. Signal Transduction Pathways as Therapeutic Targets in Cancer Therapy

    Article • September 2009, Springer Science + Business Media

    Dr Michele Milella

  15. Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments

    Article • Current Signal Transduction Therapy, May 2009, Bentham Science Publishers

    Dr Michele Milella

  16. Adjuvant Chemotherapy for Non-small Cell Lung Cancer

    Article • Journal of Thoracic Oncology, May 2007, Elsevier

    Dr Michele Milella

  17. Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress?

    Article • Cancer, January 2007, Wiley

    Dr Michele Milella

  18. Sequential chemotherapy in nonsmall-cell lung cancer

    Article • Cancer, January 2007, Wiley

    Dr Michele Milella

  19. Severe rhabdomyolysis associated with pemetrexed-based chemotherapy

    Article • The Lancet Oncology, April 2006, Elsevier

    Dr Michele Milella

  20. Aggressive chondroblastic osteosarcoma of the jawbone

    Article • Oral Oncology Extra, November 2005, Elsevier

    Dr Michele Milella

  21. Crosstalk between VEGF and Bcl-2 in Tumor Progression and Angiogenesis

    Article • January 2004, Springer Science + Business Media

    Dr Michele Milella

  22. P-627 Results from compassionate use of gefitinib (Iressa) in progressive pretreated non small cell lung cancer (NSCLC): our experience

    Article • Lung Cancer, August 2003, Elsevier

    Dr Michele Milella

  23. 13 Sequential chemotherapy in non-small cell lung cancer (NSCLC): Cisplatin and gemcitabine (P/G) followed by docetaxel (D)

    Article • Lung Cancer, August 2003, Elsevier

    Dr Michele Milella

  24. Weekly epirubicin plus lonidamine in advanced breast carcinoma

    Article • Breast Cancer Research and Treatment, August 1999, Springer Science + Business Media

    Dr Michele Milella

  25. Activation-Dependent Regulation of β1 Integrin Expression and Function in Human Natural Killer Cells

    Article • January 1993, Springer Science + Business Media

    Dr Michele Milella